The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

"In the future, the insights gained from this work could lead to the development of much-needed novel ways." Researchers ...

Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

In a leap for urban ecology, researchers have unveiled a cutting-edge method to dynamically estimate seasonal tree heights in ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

BEIJING -- Chinese scientists have developed a gene-editing technique to reduce corn plant height, enabling the creation of ...

Jennison Associates LLC lifted its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 72.6% during the 4th quarter, according to its most recent filing with the ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...